DJS Antibodies
Cara Saunders is a Research Associate at DJS Antibodies since July 2023, with prior experience as a Graduate Maths Tutor at Redbourne Upper School, where support was provided to disadvantaged students in mathematics. From September 2016 to May 2022, Cara worked at Serco as a Qualified ASA Level 1 Swimming Assistant Teacher and a Qualified Lifeguard, honing skills in communication and safety. Experience as a Biomedical Support Worker at Leeds Teaching Hospitals NHS Trust involved handling clinical trial blood samples, along with earlier volunteer work in COVID-19 testing. Cara holds a Master of Science in Chemical Biology and Drug Design and a degree in Biochemistry from the University of Leeds, supplemented by A Levels in Biology, Chemistry, and Maths from Aylesbury High School.
DJS Antibodies
1 followers
DJS Antibodies is developing novel therapeutics to treat chronic inflammatory diseases. DJS does this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs. The company's breakthrough technology enables its to produce first-in-class antibody therapeutics to previously intractable disease targets.